These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8327294)

  • 21. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
    Zhou F; Bisgard KM; Yusuf HR; Deuson RR; Bath SK; Murphy TV
    Pediatrics; 2002 Oct; 110(4):653-61. PubMed ID: 12359777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of invasive Haemophilus influenzae type b (Hib) disease in Israel.
    Dagan R
    Vaccine; 1993; 11 Suppl 1():S43-5. PubMed ID: 8447175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The decline of Haemophilus influenzae type b disease in Australia.
    Herceg A
    Commun Dis Intell; 1997 Jun; 21(13):173-6. PubMed ID: 9222159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel.
    Ginsberg GM; Kassis I; Dagan R
    J Epidemiol Community Health; 1993 Dec; 47(6):485-90. PubMed ID: 8120505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study.
    Bamberger EE; Ben-Shimol S; Abu Raya B; Katz A; Givon-Lavi N; Dagan R; Srugo I;
    Pediatr Infect Dis J; 2014 May; 33(5):477-81. PubMed ID: 24445822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease.
    McIntyre P; Hall J; Leeder S
    Aust J Public Health; 1994 Dec; 18(4):394-400. PubMed ID: 7718653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive Haemophilus influenzae type b disease in Sydney children 1985-1987: a population-based study.
    McIntyre PB; Leeder SR; Irwig LM
    Med J Aust; 1991 Jun; 154(12):832-7. PubMed ID: 2041512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, Spain.
    Asensi F; Otero MC; Pérez-Tamarit D; Miranda J; Picó L; Nieto A
    Vaccine; 1995 Nov; 13(16):1563-6. PubMed ID: 8578843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of immunization on Haemophilus influenzae type b disease.
    Madore DV
    Infect Agents Dis; 1996 Jan; 5(1):8-20. PubMed ID: 8789595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid assessment of Hib disease burden in Vietnam.
    Nyambat B; Dang DA; Nguyen HA; Mai TQ; Rani M; Slack MP; Kilgore PE
    BMC Public Health; 2011 Apr; 11():260. PubMed ID: 21513577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of Haemophilus influenzae type b disease in France.
    Reinert P; Liwartowski A; Dabernat H; Guyot C; Boucher J; Carrere C
    Vaccine; 1993; 11 Suppl 1():S38-42. PubMed ID: 8447173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia.
    Miller MA
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S152-9. PubMed ID: 9781750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
    Le P; Griffiths UK; Anh DD; Franzini L; Chan W; Swint JM
    Vaccine; 2015 Aug; 33(36):4639-46. PubMed ID: 26044493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive Haemophilus influenzae diseases and purulent meningitis in Taiwan.
    Wang CH; Lin TY
    J Formos Med Assoc; 1996 Aug; 95(8):599-604. PubMed ID: 8870429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile.
    Ferreccio C; Ortiz E; Astroza L; Rivera C; Clemens J; Levine MM
    Pediatr Infect Dis J; 1990 Jul; 9(7):488-94. PubMed ID: 2371082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
    Cochi SL; Broome CV; Hightower AW
    JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilus influenzae type B disease, vaccines, and care of exposed individuals.
    Burns IT; Zimmerman RK
    J Fam Pract; 2000 Sep; 49(9 Suppl):S7-13; quiz S14. PubMed ID: 11032188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji.
    Wilson N; Mansoor O; Wenger J; Martin R; Zanardi L; O'Leary M; Rabukawaqa V
    Vaccine; 2003 May; 21(17-18):1907-12. PubMed ID: 12706676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemophilus influenzae type b infection in children in Pacific countries.
    Carapetis JR; Russell FM; Mansoor O; Darcy A; Fakakovi T; Metai A; Potoi NT; Wilson N; Mulholland EK
    Pac Health Dialog; 2004 Mar; 11(1):79-83. PubMed ID: 18181445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophilus influenzae type b disease in the Oxford region.
    Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Slack MP; Anderson E; Rees DG; Moxon ER
    Arch Dis Child; 1989 Apr; 64(4):517-9. PubMed ID: 2787619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.